Wei‐Hsin Lin

1.5k total citations
40 papers, 1.0k citations indexed

About

Wei‐Hsin Lin is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wei‐Hsin Lin has authored 40 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 18 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wei‐Hsin Lin's work include Management of metastatic bone disease (15 papers), Bone health and treatments (6 papers) and Cancer Cells and Metastasis (5 papers). Wei‐Hsin Lin is often cited by papers focused on Management of metastatic bone disease (15 papers), Bone health and treatments (6 papers) and Cancer Cells and Metastasis (5 papers). Wei‐Hsin Lin collaborates with scholars based in Taiwan, United States and Netherlands. Wei‐Hsin Lin's co-authors include Jia-Lin Lee, Rong‐Sen Yang, Karl Wu, Yi‐Wen Chang, Shun-Min Chang, Yi-Wen Chang, Chen‐Ti Wang, Shin‐Cheh Chen, Ying-Jhen Su and Yingjian Yu and has published in prestigious journals such as Cancer Research, Journal of Bone and Joint Surgery and Oncogene.

In The Last Decade

Wei‐Hsin Lin

35 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei‐Hsin Lin Taiwan 16 326 310 271 193 172 40 1.0k
Rinat Yacobi Israel 9 270 0.8× 360 1.2× 195 0.7× 267 1.4× 81 0.5× 13 1.2k
Takatsugu Mizumachi Japan 20 346 1.1× 388 1.3× 221 0.8× 76 0.4× 422 2.5× 67 1.2k
Serpil Dızbay Sak Türkiye 15 187 0.6× 118 0.4× 245 0.9× 88 0.5× 184 1.1× 92 775
Fei Yuan China 23 473 1.5× 384 1.2× 447 1.6× 106 0.5× 314 1.8× 69 1.5k
Emiel Ruijter Netherlands 12 112 0.3× 234 0.8× 545 2.0× 192 1.0× 93 0.5× 17 835
Hans Rutz Switzerland 19 170 0.5× 161 0.5× 811 3.0× 374 1.9× 237 1.4× 37 1.4k
W. Torre Spain 14 238 0.7× 281 0.9× 494 1.8× 39 0.2× 136 0.8× 47 912
Kazem Anvari Iran 15 283 0.9× 398 1.3× 216 0.8× 27 0.1× 147 0.9× 82 1.0k
Hong‐Gyun Wu South Korea 21 336 1.0× 219 0.7× 442 1.6× 31 0.2× 347 2.0× 113 1.3k

Countries citing papers authored by Wei‐Hsin Lin

Since Specialization
Citations

This map shows the geographic impact of Wei‐Hsin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Hsin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Hsin Lin more than expected).

Fields of papers citing papers by Wei‐Hsin Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Hsin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Hsin Lin. The network helps show where Wei‐Hsin Lin may publish in the future.

Co-authorship network of co-authors of Wei‐Hsin Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Hsin Lin. A scholar is included among the top collaborators of Wei‐Hsin Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Hsin Lin. Wei‐Hsin Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Ho‐Hsiung, et al.. (2025). Systematic review of 99 extremity bone malignancy survival prediction models. Journal of Orthopaedics and Traumatology. 26(1). 5–5.
2.
Chen, Yilun, Wen-Chi Yang, Wei‐Hsin Lin, et al.. (2025). 1989 Phase II randomized trial of elective versus involved target irradiation in stereotactic spine radiosurgery (NCT04033536). Radiotherapy and Oncology. 206. S1503–S1505.
3.
Pan, Yuting, Fu‐Shan Jaw, Stein J. Janssen, et al.. (2024). Clinical, oncological, and prognostic differences of patients with subsequent skeletal-related events in bone metastases. Bone and Joint Research. 13(9). 497–506.
4.
Chang, Ruey‐Feng, Yu‐An Chen, Ming‐Hsiao Hu, et al.. (2024). Psoas muscle area is an independent survival prognosticator in patients undergoing surgery for long‐bone metastases. Cancer Medicine. 13(4). e7072–e7072. 1 indexed citations
6.
Yuan, Chen, Olivier Q. Groot, Aditya V. Karhade, et al.. (2023). Comparison of eight modern preoperative scoring systems for survival prediction in patients with extremity metastasis. Cancer Medicine. 12(13). 14264–14281. 2 indexed citations
7.
Pan, Yuting, Min‐Tsun Liao, Mao‐Hsu Yen, et al.. (2023). Determining patients with spinal metastases suitable for surgical intervention: A cost‐effective analysis. Cancer Medicine. 12(19). 20059–20069. 3 indexed citations
8.
Wu, Chun‐Yu, Yen‐Heng Lin, Yucheng Huang, et al.. (2023). Delay of Surgery for Spinal Metastasis due to the COVID-19 Outbreak Affected Patient Outcomes. Neurospine. 20(4). 1431–1442. 4 indexed citations
9.
Hu, Ming‐Hsiao, Chih‐Horng Wu, Chih‐Wei Chen, et al.. (2022). Decreased psoas muscle area is a prognosticator for 90-day and 1-year survival in patients undergoing surgical treatment for spinal metastasis. Clinical Nutrition. 41(3). 620–629. 14 indexed citations
11.
Hu, Ming‐Hsiao, Olivier Q. Groot, Aditya V. Karhade, et al.. (2022). Prognostic significance of lab data and performance comparison by validating survival prediction models for patients with spinal metastases after radiotherapy. Radiotherapy and Oncology. 175. 159–166. 8 indexed citations
12.
Chen, Chih‐Wei, Mitchell S. Fourman, Michiel E. R. Bongers, et al.. (2021). International external validation of the SORG machine learning algorithms for predicting 90-day and one-year survival of patients with spine metastases using a Taiwanese cohort. The Spine Journal. 21(10). 1670–1678. 36 indexed citations
13.
Lin, Wei‐Hsin, et al.. (2020). STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT–MET switch and cancer metastasis. Oncogene. 40(4). 791–805. 106 indexed citations
14.
Chen, Ssu‐Han & Wei‐Hsin Lin. (2020). DETERMINATION OF AN OPTIMAL PIPELINE FOR IMBALANCED CLASSIFICATION: PREDICTING POTENTIAL CUSTOMER COMPLAINTS TO A TEXTILE MANUFACTURER. International journal of industrial engineering. 27(5). 2 indexed citations
15.
Rothenstein, J., Alexander I. Spira, Vamsidhar Velcheti, et al.. (2018). P1.01-83 IMpower150: Impact of Chemotherapy Cycles in 1L Metastatic NSCLC in Patients Treated With Atezolizumab + Bevacizumab. Journal of Thoracic Oncology. 13(10). S495–S495. 3 indexed citations
16.
Chang, Yi‐Wen, Ying-Jhen Su, Michael Hsiao, et al.. (2015). Diverse Targets of β-Catenin during the Epithelial–Mesenchymal Transition Define Cancer Stem Cells and Predict Disease Relapse. Cancer Research. 75(16). 3398–3410. 77 indexed citations
17.
Chen, Chih‐Yu, Karl Wu, Wei‐Hsin Lin, et al.. (2012). High false negative rate of Tc-99m MDP whole-body bone scintigraphy in detecting skeletal metastases for patients with hepatoma. Journal of the Formosan Medical Association. 111(3). 140–146. 13 indexed citations
18.
Hu, Ming‐Hsiao, et al.. (2011). Slipped Capital Femoral Epiphysis in an Adult with Panhypopituitarism. Orthopedics. 34(3). 222–222. 7 indexed citations
19.
Wu, Karl, et al.. (2010). Treatment of Unicameral Bone Cyst. Journal of Bone and Joint Surgery. 92(4). 855–862. 131 indexed citations
20.
Lai, Hung‐Cheng, Hsin‐Yi Lee, Wei‐Hsin Lin, et al.. (2008). Valproic acid resensitizes cisplatin‐resistant ovarian cancer cells. Cancer Science. 99(6). 1218–1226. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026